Funding Trends Overview

Startup funding experienced a marked slowdown for the second consecutive week, with fewer nine-figure raises compared to previous weeks. Nonetheless, a standout round of $500 million dominated the landscape.

Top Funding Deals of the Week

1. Nerdio – $500M (Information Technology)
   Based in Chicago, Nerdio has successfully attracted a $500 million equity round led by General Atlantic, bringing its valuation to $1.2 billion. The company boasts over 15,000 customers across 50 countries and reported a year-on-year growth in annual recurring revenue exceeding 85%. Founded in 1998, Nerdio has now raised a total of $625 million, according to Crunchbase.
2. Latigo Biotherapeutics – $150M (Biotechnology)
   Originating from Thousand Oaks, California, Latigo Biotherapeutics raised $150 million in a Series B funding round led by funds managed by Blue Owl. The company focuses on developing non-opioid pain relief options and is currently advancing its clinical-stage Nav1.8 inhibitors. Since its inception in 2018, Latigo has amassed $300 million in total funding.
3. BuildOps – $127M (Commercial Contracting)
   Santa Monica-based BuildOps, which provides software solutions for managing construction and maintenance projects, secured $127 million led by Meritech Capital Partners. Founded in 2018, the company has raised over $225 million to address the $300 billion contracting industry.
4. Curevo – $110M (Biotechnology)
   Seattle’s Curevo raised $110 million in Series B funding, spearheaded by Medicxi, to facilitate the development of its shingles vaccine, amezosvatein. This clinical-stage biotech firm has raised a total of $196 million since its launch in 2018.
5. Dataminr – $85M (Analytics)
   After a hiatus from major fundraising activities, Dataminr raised $85 million through a blend of convertible financing and credit, supported by HSBC and NightDragon. While a new valuation was not disclosed, the company is nearing $200 million in annual recurring revenue. Founded in 2009, Dataminr has raised a total of $1.1 billion.
6. Arbor Biotechnologies – $74M (Biotechnology)
   Based in Cambridge, Massachusetts, Arbor Biotechnologies closed a $73.9 million Series C funding round, led by Arch Venture Partners and TCG Crossover. The company focuses on genetic medicines and has raised nearly $305 million since its founding in 2016.
7. Ampersand Biomedicines – $65M (Biotechnology)
   Boston’s Ampersand Biomedicines, known for developing targeted medicines, raised $65 million in a Series B round. Investors included Flagship Pioneering and Eli Lilly, among others, contributing to a total of $115 million raised since 2021.
8. Carbon Arc – $56M (Information Technology)
   New York-based Carbon Arc, which specializes in structured model-ready data, raised $56 million with support from Liberty City Ventures.
9. Cardiac Dimensions – $53M (Medical Device)
   This Kirkland, Washington company focuses on heart failure solutions and secured $53 million in Series E funding, aimed at international expansion and trial completion in the U.S. Cardiac Dimensions has amassed nearly $263 million to date.
10. Graphite – $52M (Developer Tools)
    New York’s Graphite raised $52 million in a Series B funding led by Accel. The company, which focuses on code review tools, has raised a total of $72 million since its establishment in 2020.

Notable Global Funding

The largest funding round outside the U.S. this week was led by U.K.-based Maxion Therapeutics, which successfully raised approximately $75 million in a Series A funding round.

Research Methodology

This report lists the most substantial funding rounds recorded from March 15 to March 21, 2025, as sourced from the Crunchbase database. It is important to note that some rounds may experience reporting delays.